Literature DB >> 29741568

Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma.

K Sasaki1, J Uehara2, S Iinuma2, H Doi2, M Honma2, Y Toki3, A Ishida-Yamamoto2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29741568     DOI: 10.1093/annonc/mdy175

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy.

Authors:  Karim R Saab; Meghan J Mooradian; Daniel Y Wang; Jeewon Chon; Cathy Y Xia; Angelica Bialczak; Kelly T Abbate; Alexander M Menzies; Douglas B Johnson; Ryan J Sullivan; Alexander N Shoushtari
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

2.  Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.

Authors:  Roberta Noseda; Raffaela Bertoli; Laura Müller; Alessandro Ceschi
Journal:  J Immunother Cancer       Date:  2019-05-02       Impact factor: 13.751

3.  Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.

Authors:  Adeel Masood; Ahsan Wahab; Tanya Clifford; Eric J Weaver; Hamid Ehsan; Walid El Ayass
Journal:  Clin Case Rep       Date:  2021-12-05

Review 4.  Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.

Authors:  Jaime Rubio-Perez; Ángel Ricardo Rodríguez-Perez; María Díaz-Blázquez; Victor Moreno-García; Manuel Dómine-Gómez
Journal:  J Med Case Rep       Date:  2022-10-04

5.  Encephalitis Associated With Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitors: An Unfamiliar Spin-Off.

Authors:  Ghulam Ghous; Hafiz Muhammad Hassan Shoukat; Zahid Ijaz Tarar; Muhammad Usman Zafar; Joseph W McGreevy
Journal:  Cureus       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.